New Resource from National Comprehensive Cancer Network Breaks the Silence on Common but Lesser-Known Cause of Cancer Deaths
PLYMOUTH MEETING, Pa., Sept. 7, 2023 /PRNewswire/ -- The National Comprehensive Cancer Network (NCCN®) today announced the publication of a new supportive care patient guideline focused on preventing and treating cancer-associated blood clots, also known as venous thromboembolism (VTE). Research shows that people with cancer are nine times more likely to experience blood clots than those without cancer. Blood clots are a leading cause of death for people with cancer, second only to the direct effects of the cancer itself.1,2
- Research shows that people with cancer are nine times more likely to experience blood clots than those without cancer.
- Blood clots are a leading cause of death for people with cancer, second only to the direct effects of the cancer itself.1,2
Research shows that people with cancer are nine times more likely to experience blood clots than those without cancer. - "Cancer is a strong risk factor for developing a blood clot, and thrombosis is the second leading cause of death in patients with cancer.
- Preventing and treating blood clots is also discussed in several relevant disease-specific NCCN patient guidelines, including for pancreatic cancer, multiple myeloma, and myeloproliferative neoplasms.